APA

Kendra K. L., Plummer R., Salgia R., O'Brien M. E. R., Paul E. M., Suttle A. B., Compton N., Xu C., Ottesen L. H. & Villalona-Calero M. A. (20151103). A multicenter phase I study of pazopanib in combination with paclitaxel in first-line treatment of patients with advanced solid tumors. : Molecular cancer therapeutics.

Chicago

Kendra Kari L, Plummer Ruth, Salgia Ravi, O'Brien Mary E R, Paul Elaine M, Suttle A Benjamin, Compton Natalie, Xu Chun-Fang, Ottesen Lone H and Villalona-Calero Miguel A. 20151103. A multicenter phase I study of pazopanib in combination with paclitaxel in first-line treatment of patients with advanced solid tumors. : Molecular cancer therapeutics.

Harvard

Kendra K. L., Plummer R., Salgia R., O'Brien M. E. R., Paul E. M., Suttle A. B., Compton N., Xu C., Ottesen L. H. and Villalona-Calero M. A. (20151103). A multicenter phase I study of pazopanib in combination with paclitaxel in first-line treatment of patients with advanced solid tumors. : Molecular cancer therapeutics.

MLA

Kendra Kari L, Plummer Ruth, Salgia Ravi, O'Brien Mary E R, Paul Elaine M, Suttle A Benjamin, Compton Natalie, Xu Chun-Fang, Ottesen Lone H and Villalona-Calero Miguel A. A multicenter phase I study of pazopanib in combination with paclitaxel in first-line treatment of patients with advanced solid tumors. : Molecular cancer therapeutics. 20151103.